Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03925987 · ClinicalTrials.gov registry record · NA
Predicting Treatment Response to Exposure Therapy Using Carbon Dioxide
A NA study, sponsored by Laureate Institute for Brain Research.
- Completed
- Registry status
- NA
- Development phase
- 70
- Enrollment target
NCT03925987 is a NA study that has completed, run by Laureate Institute for Brain Research. The registered enrollment target is 70 participants.
The verdict
NCT03925987, a NA study, has completed, sponsored by Laureate Institute for Brain Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
Study Summary
Anxiety disorders affect over a quarter of the population, yet very little is known about the variables that predict treatment outcome. The planned study explores whether a patient's response to a physiological test involving inhalation of carbon dioxide predicts their response to exposure therapy.
Interventions
- BEHAVIORAL Exposure therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2018-06-07 |
| Est. Completion | 2020-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03925987
The ClinicalTrials.gov registry entry for NCT03925987 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Laureate Institute for Brain Research, which has 45 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Exposure therapy is the first listed.
NCT03925987 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03925987 about?
NCT03925987 is a clinical study titled "Predicting Treatment Response to Exposure Therapy Using Carbon Dioxide". Anxiety disorders affect over a quarter of the population, yet very little is known about the variables that predict treatment outcome. The planned study explores whether a patient's response to a physiological test involving inhalation of carbon dioxide predicts their response to exposure therapy.
What is the current status of trial NCT03925987?
This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2018-06-07. Estimated completion is 2020-07-31.
What interventions are being tested in trial NCT03925987?
The interventions under investigation include: Exposure therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT03925987?
This trial is sponsored by Laureate Institute for Brain Research, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.